ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer

Abstract: Small‐cell lung cancer (SCLC) is the most lethal type of lung cancer. Specifically, MYC‐driven non‐neuroendocrine SCLC is particularly resistant to standard therapies. Lurbinectedin was recently approved for the treatment of relapsed SCLC, but combinatorial approaches are needed to increase the depth and duration of responses to lurbinectedin. Using high‐throughput screens, we found inhibitors of ataxia telangiectasia mutated and rad3 related (ATR) as the most effective agents for augmenting lurbinectedin efficacy. First‐in‐class ATR inhibitor berzosertib synergized with lurbinectedin in multiple SCLC cell lines, organoid, and in vivo models. Mechanistically, ATR inhibition abrogated S‐phase arrest induced by lurbinectedin and forced cell cycle progression causing mitotic catastrophe and cell death. High CDKN1A/p21 expression was associated with decreased synergy due to G1 arrest, while increased levels of ERCC5/XPG were predictive of increased combination efficacy. Importantly, MYC‐driven non‐neuroendocrine tumors which are resistant to first‐line therapies show reduced CDKN1A/p21 expression and increased ERCC5/XPG indicating they are primed for response to lurbinectedin–berzosertib combination. The combination is being assessed in a clinical trial NCT04802174.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer ; day:25 ; month:07 ; year:2023 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; (25.07.2023) (gesamt 17)

Urheber
Schultz, Christopher W.
Zhang, Yang
Elmeskini, Rajaa
Zimmermann, Astrid
Fu, Haiqing
Murai, Yasuhisa
Wangsa, Darawalee
Kumar, Suresh
Takahashi, Nobuyuki
Atkinson, Devon
Saha, Liton Kumar
Lee, Chien‐Fei
Elenbaas, Brian
Desai, Parth
Sebastian, Robin
Sharma, Ajit Kumar
Abel, Melissa
Schroeder, Brett
Krishnamurthy, Manan
Kumar, Rajesh
Roper, Nitin
Aladjem, Mirit
Zenke, Frank T.
Ohler, Zoe Weaver
Pommier, Yves
Thomas, Anish

DOI
10.15252/emmm.202217313
URN
urn:nbn:de:101:1-2023072615175067772183
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:59 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Schultz, Christopher W.
  • Zhang, Yang
  • Elmeskini, Rajaa
  • Zimmermann, Astrid
  • Fu, Haiqing
  • Murai, Yasuhisa
  • Wangsa, Darawalee
  • Kumar, Suresh
  • Takahashi, Nobuyuki
  • Atkinson, Devon
  • Saha, Liton Kumar
  • Lee, Chien‐Fei
  • Elenbaas, Brian
  • Desai, Parth
  • Sebastian, Robin
  • Sharma, Ajit Kumar
  • Abel, Melissa
  • Schroeder, Brett
  • Krishnamurthy, Manan
  • Kumar, Rajesh
  • Roper, Nitin
  • Aladjem, Mirit
  • Zenke, Frank T.
  • Ohler, Zoe Weaver
  • Pommier, Yves
  • Thomas, Anish

Ähnliche Objekte (12)